Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Lutheran Hospital
mi
from
Fort Wayne, IN
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Lutheran Hospital
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
University of Iowa Hospital and Clinics
mi
from
Iowa City, IA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
University of Iowa Hospital and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
University of Kansas Hospital
mi
from
Kansas City, KA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
University of Kansas Hospital
mi
from
Kansas City, KA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Baptist Hospital East
mi
from
Louiseville, KY
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Baptist Hospital East
mi
from
Louiseville, KY
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Our Lady of the Lake Regional Medical Center
mi
from
Baton Rouge, LA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Our Lady of the Lake Regional Medical Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Washington Adventist Hospital
mi
from
Takoma Park, MD
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Washington Adventist Hospital
mi
from
Takoma Park, MD
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
BryanLGH Heart Institute
mi
from
Lincoln, NE
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
BryanLGH Heart Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Creighton University Medical Center
mi
from
Omaha, NE
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
North Shore University Hospital
mi
from
Manhasset, NY
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
New York-Presbyterian Hospital, Columbia Univ MC
mi
from
New York, NY
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
New York-Presbyterian Hospital, Columbia Univ MC
mi
from
New York, NY
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
St. Francis Hospital
mi
from
Roslyn, NY
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
St. Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Bethesda North Hospital
mi
from
Cincinnati, OH
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
University of Cincinnati
mi
from
Cincinnati, OH
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Riverside Methodist Hospital
mi
from
Columbus, OH
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Genesis Healthcare Systems
mi
from
Zanesville, OH
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Genesis Healthcare Systems
mi
from
Zanesville, OH
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Doylestown Hospital
mi
from
Doylestown, PA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Albert Einstein Medical Center
mi
from
Philadelphia, PA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Centennial Medical Center
mi
from
Ashland City, TN
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Centennial Medical Center
mi
from
Ashland City, TN
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Plaza Medical Center
mi
from
Fort Worth, TX
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Plaza Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Bellin Memorial Hospital
mi
from
Green Bay, WI
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Bellin Memorial Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)
A Randomized, Placebo- And Positive-Controlled Cross-Over Study To Evaluate The Effect Of Tafamidis On The QTC Interval In Healthy Volunteers
Status: Enrolling
Updated:  3/4/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)
A Randomized, Placebo- And Positive-Controlled Cross-Over Study To Evaluate The Effect Of Tafamidis On The QTC Interval In Healthy Volunteers
Status: Enrolling
Updated: 3/4/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Status: Enrolling
Updated:  3/4/2013
Westside Medical Associates of Los Angeles
mi
from
Beverly Hills, CA
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Status: Enrolling
Updated: 3/4/2013
Westside Medical Associates of Los Angeles
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Positive Psychology to Improve Cardiac Health Behaviors
Developing a Positive Psychology Intervention to Improve Cardiac Health Behaviors: Qualitative Research Phase
Status: Enrolling
Updated:  3/6/2013
Massachusetts General Hospital
mi
from
Boston, MA
Positive Psychology to Improve Cardiac Health Behaviors
Developing a Positive Psychology Intervention to Improve Cardiac Health Behaviors: Qualitative Research Phase
Status: Enrolling
Updated: 3/6/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
Status: Enrolling
Updated:  3/7/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
Status: Enrolling
Updated: 3/7/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Pocket Echocardiography System (PES) for Detection of Patent Ductus Arteriosus (PDA) in Neonates
Status: Enrolling
Updated:  3/11/2013
University of Florida
mi
from
Gainesville, FL
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Pocket Echocardiography System (PES) for Detection of Patent Ductus Arteriosus (PDA) in Neonates
Status: Enrolling
Updated: 3/11/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency
An Open-label, Single-dose Study of the Safety, Tolerability, and Pharmacokinetics of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency and Effect of Hemodialysis on AMG 423 Pharmacokinetics
Status: Enrolling
Updated:  3/12/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency
An Open-label, Single-dose Study of the Safety, Tolerability, and Pharmacokinetics of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency and Effect of Hemodialysis on AMG 423 Pharmacokinetics
Status: Enrolling
Updated: 3/12/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
Status: Enrolling
Updated:  3/13/2013
GW University
mi
from
Washington,
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
Status: Enrolling
Updated: 3/13/2013
GW University
mi
from
Washington,
Click here to add this to my saved trials
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated:  3/19/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated: 3/19/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated:  3/19/2013
Loyola University
mi
from
Maywood, IL
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated: 3/19/2013
Loyola University
mi
from
Maywood, IL
Click here to add this to my saved trials
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated:  3/19/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated: 3/19/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated:  3/19/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated: 3/19/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated:  3/19/2013
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated: 3/19/2013
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated:  3/19/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
Status: Enrolling
Updated: 3/19/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pharmacogenomics of Antiplatelet Response - I
PHARMACOGENOMICS OF ANTI-PLATELET RESPONSE - I
Status: Enrolling
Updated:  3/19/2013
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Pharmacogenomics of Antiplatelet Response - I
PHARMACOGENOMICS OF ANTI-PLATELET RESPONSE - I
Status: Enrolling
Updated: 3/19/2013
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Status: Enrolling
Updated:  3/20/2013
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Status: Enrolling
Updated: 3/20/2013
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Prospective Observation of Exercise Parameters in Advanced Heart Failure
Prospective Observation of Exercise Parameters in Advanced Heart Failure
Status: Enrolling
Updated:  3/20/2013
Masonic Clinical Research Unit
mi
from
Minneapolis, MN
Prospective Observation of Exercise Parameters in Advanced Heart Failure
Prospective Observation of Exercise Parameters in Advanced Heart Failure
Status: Enrolling
Updated: 3/20/2013
Masonic Clinical Research Unit
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Default Options in Advance Directives
Default Options in Advance Directives for Veterans With Serious Illnesses: A Randomized Clinical Trial
Status: Enrolling
Updated:  3/21/2013
Philadelphia Veterans Affairs Medical Center
mi
from
Philadelphia, PA
Study of Default Options in Advance Directives
Default Options in Advance Directives for Veterans With Serious Illnesses: A Randomized Clinical Trial
Status: Enrolling
Updated: 3/21/2013
Philadelphia Veterans Affairs Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
Minnesota Heart Failure Network
mi
from
Minneapolis, MN
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
Minnesota Heart Failure Network
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
Baylor College of Medicine
mi
from
Houston, TX
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated:  3/22/2013
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network ROSE Study
Status: Enrolling
Updated: 3/22/2013
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
Prophylactic Remote Ischemic Preconditioning for Cerebral Vasospasm Following Subarachnoid Hemorrhage
Status: Enrolling
Updated:  3/24/2013
UCLA Ronald Reagan Medical Center
mi
from
Los Angeles, CA
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
Prophylactic Remote Ischemic Preconditioning for Cerebral Vasospasm Following Subarachnoid Hemorrhage
Status: Enrolling
Updated: 3/24/2013
UCLA Ronald Reagan Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 053
mi
from
Birmingham, AL
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 053
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 048
mi
from
Huntsville, AL
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 048
mi
from
Huntsville, AL
Click here to add this to my saved trials
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 013
mi
from
Phoenix, AZ
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 013
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 110
mi
from
Los Angeles, CA
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 110
mi
from
Los Angeles, CA
Click here to add this to my saved trials